HGC Investment Management’s Ibere Pharmaceuticals IBER Stock Holding History

HGC Investment Management’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-49,023	Closed	-$495K	–	331
2022 Q4	$495K	Buy	+49,023	New	+$490K	0.05%	197

HGC Investment Management's IBER Position: Q1 2023 in Review

HGC Investment Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 49,023 shares — an estimated $495K sold.

HGC Investment Management first reported a position in IBER in Q4 2022 and held it in 1 quarter. The position peaked at $495K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

HGC Investment Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
HGC Investment Management sold 49,023 Ibere Pharmaceuticals shares in Q1 2023, an estimated $495K.
HGC Investment Management first reported a position in Ibere Pharmaceuticals in Q4 2022 and held it in 1 quarter.
HGC Investment Management's Ibere Pharmaceuticals position peaked at $495K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on HGC Investment Management's 13F filing for Q1 2023, filed 15 May 2023.